https://www.selleckchem.com/products/drb18.html
In contrast, long-chain ceramides were significantly increased in AIS patients. More importantly, higher levels of Cer(d181/18, Cer(d181/20, and Cer(d181/22 at 48-72h were significantly associated with poor functional outcomes after adjusting for potential clinical confounders, including age, sex, hypertension, and National Institutes of Health Stroke Scale score at admission. Our study supported the dynamic metabolism of sphingolipids after the occurrence of AIS. Ceramides could be potential prognostic markers for patients with AIS
Like
Comment
Share
